For your interest: a mini-symposium on “Cities After COVID” in TPM: The Philosophers’ Magazine. Yours truly has a bite-sized contribution about two-thirds of the way down, “The Pedestrian Death Crisis at the Intersection”: hyper-applied philosophy offered pro bono publicum. Thanks to Ian Olasov for putting the symposium together, and to everyone who’s had to endure the traffic/pedestrian safety rants that led to my essay. But don’t stop at that particular intersection; drive through and check out the whole thing.
Tag Archives: COVID-19
Fatal Vision: Boosters, Variants, and Equity
Getting a booster is no panacea, but not getting one may be a fatal mistake. That, at any rate, is the finding of a set of Israeli studies in the New England Journal of Medicine, one published in October, the other published just a few days ago. An excerpt from the abstract of the “Conclusions” section of the latter:
Across the age groups studied, rates of confirmed Covid-19 and severe illness were substantially lower among participants who received a booster dose of the BNT162b2 vaccine than among those who did not.
Read both articles all the way through for all of the relevant provisos and qualifications, but I think it’s fair to summarize both by saying that they jointly found that boosters reduced the incidence of both serious morbidity and mortality due to COVID-19, inclusive of all variants but Omicron (about which it’s too early to tell). Continue reading
Hit Me with Your Best Shot
Well, it looks like the pro-booster side has essentially won the argument, at least in the US, over whether boosters ought to be given for recipients of the Pfizer-Biontech COVID vaccine, six+ months after the second dose. My brother Suleman and I have (very incompletely) argued the case in favor of boosters here, here, and here. As front-line health care workers (he’s a physician, I worked in OR EVS), we got our first doses of the shot back in December 2020, and our second ones in January 2021. He works with COVID patients in a hospital, and I work in an increasingly crowded office. Neither of us had any sense of how much protection we were getting from the vaccine at this point.
Continue readingThe Waiting Is the Hardest Part: Booster Shots Revisited
So here is the report from The New York Times we all could have guessed we’d find ourselves reading one of these mornings.
While it is premature to conclude that the pause and retrenchment on government approval of booster vaccines will prove to be a permanent one, I’d be remiss if I didn’t point out the following:
Continue readingWho Made WHO: COVID-19, Global Class Warfare, and Booster Shots
Who pick up the bill when who made who? Ain’t nobody told you?
–AC/DC
On August 18th, The New York Times ran a story on the front of its feed titled “Booster Shots ‘Make a Mockery of Vaccine Equity,’ the WHO’s Africa director says.” In case that statement sounds needlessly inflammatory and emotionally manipulative, here’s the actual quote from Dr. Matshidiso Moeti:
Moves by some countries globally to introduce booster shots threaten the promise of a brighter tomorrow for Africa. As some richer countries hoard vaccines, they make a mockery of vaccine equity.
To say that the introduction of a booster program in one nation poses a near-existential threat to a continent of 1.2 billion people is a stretch. But it’s not until you drill down to the factual details of the worldwide dynamic of COVID prevalence, vaccine production, and actual vaccination that you get a sense of how misleading and irresponsible that statement is, and how shaky is Moeti’s subsequent claim that as a consequence of boosters, more dangerous variants of COVID will arise.
Continue readingCOVID Booster Shot Meets Health Care Monopoly
This post is part of an occasional series on health care. Here’s the prologue to the series, which originally preceded the post below.
Here’s a fairly straightforward story from The New York Times from a few days back, reminding us of the fact that immunity from some of the COVID vaccinations is limited in time, and may well require a booster shot.
WASHINGTON — Biden administration health officials increasingly think that vulnerable populations will need booster shots even as research continues into how long the coronavirus vaccines remain effective.
Senior officials now say they expect that people who are 65 and older or who have compromised immune systems will most likely need a third shot from Pfizer-BioNTech or Moderna, two vaccines based on the same technology that have been used to inoculate the vast majority of Americans thus far. That is a sharp shift from just a few weeks ago, when the administration said it thought there was not enough evidence to back boosters yet.
On Thursday, a key official at the Centers for Disease Control and Prevention said the agency is exploring options to give patients with compromised immune systems third doses even before regulators broaden the emergency use authorization for coronavirus vaccines, a step that could come soon for the Pfizer vaccine.
Skipping a bit:
Pfizer’s continuing global study of its clinical trial participants shows that four to six months after the second dose, the vaccine’s effectiveness against symptomatic infection drops from a high of 95 percent to 84 percent, according to the company.
As a (then) full-time hospital worker actively exposed to high concentrations of COVID, I got my second dose of the Pfizer-BioNTech shot on January 6. If the vaccine’s effectiveness definitely drops from 95% to 84% in four to six months, then I’m well past my due date for a booster. Though I’m no longer a full-time hospital worker, I’ve been waiting for twelve weeks now for the paperwork to go through on my bid to work per diem for Hunterdon Medical Center’s OR. Assuming it goes through, I’ll be back in the COVID-intensive environment I previously inhabited. And if it doesn’t go through, I intend to apply to do the same work at a different hospital. So one way or another, I intend to make my way back to hospital work, and (by implication) to re-immerse myself in COVID.
Continue readingPaul Krugman on Masks and Public Urination
I agree with Paul Krugman about masking, but he’s wrong about public urination, and wrong to use the laws against it as an analogue of the laws requiring masking in the COVID-19 pandemic:
Relieving yourself in public is illegal in every state. I assume that few readers are surprised to hear this; I also assume that many readers wonder why I feel the need to bring up this distasteful subject. But bear with me: There’s a moral here, and it’s one that has disturbing implications for our nation’s future.
Although we take these restrictions for granted, they can sometimes be inconvenient, as anyone out and about after having had too many cups of coffee can attest. But the inconvenience is trivial, and the case for such rules is compelling, both in terms of protecting public health and as a way to avoid causing public offense. And as far as I know there aren’t angry political activists, let alone armed protesters, demanding the right to do their business wherever they want.
Laws against public urination do not impose a merely trivial inconvenience. If someone has a medical condition that involves urinary frequency or urgency, and there are no public bathrooms available (as often there aren’t), discreet “public” urination becomes unavoidable. Likewise if someone is homeless. Continue reading
The Pfizer-Biontech Vaccine: Firstcomers and Latecomers
In a paper I’ve mentioned here before, Pierre LeMorvan and Barbara Stock discuss a moral dilemma that arises from the ubiquity, in health care, of what they call “the medical learning curve.” The idea is that neophyte health care workers face a learning curve that puts patients at risk: the earlier I am in my career as a health care worker, the less skilled and knowledgeable I’m apt to be, and the more prone to error. The more error-prone I am, the more likely to impose medically dangerous risks on patients. Since health care workers need to practice their knowledge and skills on patients in order to achieve proficiency, this situation is ineliminable, even with the best supervision by more experienced practitioners. Continue reading
Stand Up with Aristotle
When I first read Aristotle’s Nicomachean Ethics maybe thirty years ago, I was both puzzled and disappointed by his discussion of the moral virtues in Book IV–generosity, magnificence, friendliness, wit, and so on. It seemed a waste of space. A whole book on this? What were such banalities doing in a classic work of moral philosophy?
Aristotle’s (very brief) discussion of the place of humor in social life seemed a case in point. On Aristotle’s account, wit turned out to be a moral virtue, buffoonery and humorlessness, vices.
Those who go to excess in raising laughs seem to be vulgar buffoons. They stop at nothing to raise a laugh, and care more about that than about saying what is seemly and avoiding pain to the victims of the joke. …
Those who joke in appropriate ways are called witty, or in other words, agile-witted. For these sorts of jokes seem to be movements of someone’s character, and characters are judged, as bodies are, by their movements (NE IV.8, 1128a5-12).
Really? That’s what morality requires? Telling the right jokes at the right time, in the right way, for the right reasons, etc. etc.? Continue reading
Thanksgiving, Gratitude, and the Flower of Life
Today is Thanksgiving, a day on which it’s appropriate to give public thanks for the gifts we’ve received from life itself. Until recently, I had great disdain for Thanksgiving–just last year, I wrote a bitchy attack on it–mostly because until recently, bitterness and resentment were my favorite go-to emotions.
Paradoxically, I had to lose a lot in the past few months to appreciate what I have, and to grasp the true meaning of gratitude: a job, a marriage, a house, a car, tens of thousands of dollars, hundreds of hours of labor, and a large handful of illusions, for starters. I sold the house, but stand to make very little from it, so I count it as a loss. I sold the car for a ridiculously lowball figure, so I regard that as a loss. I’m in litigation, make a nominal wage at a dirty job doing hard physical labor, and lack permanent housing or the means to pay for it. I have temporary housing, but it lacks running water. So there are challenges. And yet, life has never been better. Last year, I had everything I now lack, and made sure to get up bright and early “to take a crap on Thanksgiving.” Now I’m writing a paean to gratitude. What a difference a year makes. Continue reading